ACTIVE

ReWind Therapeutics

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-4,6 M €
+2.3% YoY
Gross margin
-528,3 k €
-338.2% YoY
Equity
-2,6 M €
+70.3% YoY
Workforce
4,9 ETP
-43.0% YoY

What does ReWind Therapeutics do?

ReWind Therapeutics is a Public limited company incorporated in 2017. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven. It employs on average 4,9 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0682.626.216
Incorporation
06/10/2017
Legal form
Public limited company
Registered office
Gaston Geenslaan 3
3001 Leuven · FlandreSee on map
Contributed capital
2 755 035,17 €
Latest accounts
31/12/2025
Average workforce
4,9 ETP
Activities (NACE)
72101Research and experimental development on natural sciences and engineering· main72110Research and experimental development on biotechnology
Joint committees (1)
  • 207
Signals
Healthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 7 financial years

2025202420232022202120202019
Income statement
Gross margin-528,3 k €-120,5 k €-241,8 k €-294,5 k €678,7 k €-297,5 k €312,4 k €
EBITDA-1,2 M €-1,2 M €-1,3 M €-1,2 M €83,6 k €-637,1 k €198,0 k €
Operating result-4,3 M €-4,1 M €-5,4 M €-4,5 M €-3,0 M €-3,6 M €-2,4 M €
Net result-4,6 M €-4,7 M €-5,7 M €-4,5 M €-2,9 M €-3,5 M €-2,3 M €
Balance sheet
Equity-2,6 M €-8,8 M €-4,0 M €1,6 M €6,1 M €5,9 M €9,4 M €
Total assets2,1 M €2,7 M €3,6 M €6,2 M €6,5 M €6,3 M €9,9 M €
Cash1,3 M €1,6 M €2,5 M €5,2 M €4,9 M €5,2 M €8,4 M €
Debts4,4 M €11,5 M €7,6 M €4,5 M €392,4 k €440,4 k €495,2 k €
Other
Workforce4,9 ETP8,6 ETP9,6 ETP7,7 ETP6,0 ETP2,8 ETP1,0 ETP
Governance

Board of directors

Seen on filing of 31/12/2025 · 8 active · 18 ended

Active mandates

Paul Nicklin

Director · since 17 mars 2025

Active
BIOSKILLS

Chairman of the board of directors · since 16 mai 2024 · until 16 mai 2030 · 0525.916.875

Represented by Jim VAN HEUSDEN

Active
Cornelis Been

Director · since 16 mai 2024 · until 16 mai 2030

Active
Participatiemaatschappij Vlaanderen

Director · since 16 mai 2024 · until 16 mai 2030 · 0455.777.660

Represented by Tobias Wilms

Active
Bauke Anninga

Director · since 08 mai 2024 · until 16 mai 2030

Active
Claus Asbjorn Andersson

Director · since 27 janvier 2023 · until 26 janvier 2029

Active
Stefaan Allemeersch

Director · since 27 juin 2022 · until 20 mai 2027

Active
Stefan Lohmer

Director · since 27 juin 2022 · until 20 mai 2027

Active

Ended mandates

Bauke Anninga

Director · since 07 décembre 2023 · until 06 décembre 2029

Ended
Anhabio Consulting GmbH

Persoon belast met dagelijks bestuur · since 20 septembre 2021 · until 20 mai 2027

Represented by Anja Harmeier

Ended
Been CORNELIS

Director · since 01 août 2020 · until 16 mai 2024

Ended
Participatiemaatschappij Vlaanderen

Director · since 06 mai 2020 · until 16 mai 2024 · 0455.777.660

Represented by Alexandra TOLIA

Ended
At this address

Other companies at this address

CompanyCBE no.
AstriVax Therapeutics● Active
0787.990.881
AUGUSTINE THERAPEUTICS● Active
0722.705.230
COULTREON BIOPHARMA● Active
1019.429.814
K5 Therapeutics● Active
0757.718.072
Metaptys● Active
0554.664.311
Montis Biosciences● Active
0730.979.429
Perseus Biomics● Active
0650.946.412
QUOMAK● Active
0448.488.111
Stichting Administratiekantoor Coultreon● Active
1040.853.946
Tavira Therapeutics● Active
0802.591.262
VEDRA THERAPEUTICS● Active
1039.565.628
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date08/07/202626/05/202517/05/202431/05/202331/08/202217/06/2021
General meeting30/06/202615/05/202516/05/202422/05/202327/06/202210/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

9 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202608/07/2026DutchPDF
Abridged model31/12/202415/05/202526/05/2025DutchPDF
Abridged model31/12/202316/05/202417/05/2024DutchPDF
Abridged model31/12/202222/05/202331/05/2023DutchPDF
Abridged modelCorrection31/12/202127/06/202231/08/2022DutchPDF
Abridged model31/12/202119/05/202230/06/2022DutchPDF
Abridged model31/12/202010/06/202117/06/2021DutchPDF
Abridged model31/12/201922/05/202008/06/2020DutchPDF
Micro model31/12/201816/05/201906/06/2019DutchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 8 active · 18 ended

Active mandates

Paul Nicklin

Director · since 17 mars 2025

Active
BIOSKILLS

Chairman of the board of directors · since 16 mai 2024 · until 16 mai 2030 · 0525.916.875

Represented by Jim VAN HEUSDEN

Active
Cornelis Been

Director · since 16 mai 2024 · until 16 mai 2030

Active
Participatiemaatschappij Vlaanderen

Director · since 16 mai 2024 · until 16 mai 2030 · 0455.777.660

Represented by Tobias Wilms

Active
Bauke Anninga

Director · since 08 mai 2024 · until 16 mai 2030

Active
Claus Asbjorn Andersson

Director · since 27 janvier 2023 · until 26 janvier 2029

Active
Stefaan Allemeersch

Director · since 27 juin 2022 · until 20 mai 2027

Active
Stefan Lohmer

Director · since 27 juin 2022 · until 20 mai 2027

Active

Ended mandates

Bauke Anninga

Director · since 07 décembre 2023 · until 06 décembre 2029

Ended
Anhabio Consulting GmbH

Persoon belast met dagelijks bestuur · since 20 septembre 2021 · until 20 mai 2027

Represented by Anja Harmeier

Ended
Been CORNELIS

Director · since 01 août 2020 · until 16 mai 2024

Ended
Participatiemaatschappij Vlaanderen

Director · since 06 mai 2020 · until 16 mai 2024 · 0455.777.660

Represented by Alexandra TOLIA

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Capital / shares13/08/2026
    KAPITAAL, AANDELEN, STATUTEN (VERTALING, COORDINATIE,
    PDF
  • Mandates13/03/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates17/09/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/04/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares10/03/2025
    KAPITAAL - AANDELEN
    PDF
  • Mandates29/08/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates03/01/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/04/2023
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-4,6 M €↑
  2. 2024
    Annual accounts 2024-4,7 M €↑
  3. 2023
    Annual accounts 2023-5,7 M €↓
  4. 2022
    Annual accounts 2022-4,5 M €↓
  5. 2021
    Annual accounts 2021-2,9 M €↑
  6. 2020
    Annual accounts 2020-3,5 M €↓
  7. 2019
    Annual accounts 2019-2,3 M €
  8. 06/10/2017
    IncorporationPublic limited company